# Hour 11: 11:00-11:59 - Late Morning Peak

Released on 1 May 2026 | CEO Kevin Kawchak | ChemicalQDevice

## Hour Summary
Late-morning peak. 8 new arrivals, 3 departures. PAT-CONT-0045A IND C2D8 dose
delivered cleanly. AE-002: PAT-CONT-0026A grade 1 nausea (post-IND C2D1 ~3h).

## Cross-Site Status at 11:00
SITE-A 19/3 active, SITE-B 13/2, SITE-C 9/1, SITE-D 7/0.

## New Arrivals
| ID | Site | Cancer | Robot |
|----|------|--------|-------|
| PAT-CONT-0046A | SITE-A | NSCLC RT19 | RT (3+7) |
| PAT-CONT-0047A | SITE-B | Sarcoma BX | Cobot |
| PAT-CONT-0048A | SITE-C | SCLC restage | Imaging |
| PAT-CONT-0049A | SITE-A | Mediastinal pre-op | Surgical |
| PAT-CONT-0050A | SITE-D | Pediatric ALL maintenance | Companion |
| PAT-CONT-0051A | SITE-B | HCC ablation | Steerable |
| PAT-CONT-0052A | SITE-A | Brain GBM RT10 | RT (3+7) |
| PAT-CONT-0053A | SITE-C | Mantle cell BX | Cobot |

## Activity Log
```
11:00 FDA recon 6/6 ack from hour 10.
11:00-11:32 HUMAN-01 SITE-B IND C2D8 infusion (PAT-0045A).
11:05-11:28 RTPOS+TRACK SITE-A NSCLC RT19 (PAT-0046A).
11:12-11:25 COBOT-04 SITE-B sarcoma BX (PAT-0047A).
11:18-11:38 IMAGE-01 SITE-C SCLC restage (PAT-0048A).
11:24 AE-002 flagged: PAT-CONT-0026A grade 1 nausea, post-IND ~3h.
      Priority RTCT signal sent. FDA ack 11:24+8s. Antiemetic given.
11:28 RT endpoint TRAVERSE-CONT-0046A-RT19 ack 10s.
11:30-11:55 SURG-02 SITE-A mediastinal resection (PAT-0049A).
11:32 IND endpoint TRAVERSE-CONT-0045A-IND-C2D8 ack 9s.
11:38 IMG endpoint STREAM-CONT-0048A-RESTAGE ack 12s.
11:40-11:55 COMPN-04 SITE-D pediatric maintenance (PAT-0050A).
11:42-11:59+ STEER-02 SITE-B HCC ablation prep (PAT-0051A).
11:48-11:59+ RTPOS-03+TRACK-03 SITE-A GBM RT10 (PAT-0052A).
11:54-11:59+ COBOT-01 SITE-C mantle BX (PAT-0053A).
11:55 SURG endpoint TRAVERSE-CONT-0049A-SURG01 ack 11s.
11:55 PED endpoint TRAVERSE-PED-CONT-0050A-MAINT01 ack 10s.
```

## Departures (3)
- PAT-CONT-0006 11:10 (post-RT 10h obs).
- PAT-CONT-0023A 11:25 (post-biopsy 24h).
- PAT-CONT-0025A 11:40 (CT review consult complete).

## Adverse Events
- **AE-002**: PAT-CONT-0026A grade 1 nausea, expected per IB. Resolved
  by 12:30 with antiemetic.

## IND
PAT-CONT-0045A C2D8 ARM-A 60 mg complete.

## Utilization
SITE-A 79, SITE-B 71, SITE-C 38, SITE-D 15. Network util 2.91%.

## RTCT Stream
7 endpoints + 1 priority AE. Priority ack 8 s.
